What's next for Ebos after the end of that Chemist Warehouse contract

What's next for Ebos after the end of that Chemist Warehouse contract
CEO John Cullity says there isn't double-digit growth to be found in animal or healthcare in Australasia. (Image: Ebos)
Rebecca Stevenson
Ebos chief executive John Cullity says the firm must hunt outside of Australasia for double-digit growth. The dual-listed healthcare and pharmaceutical marketer and wholesaler was looking for growth outside its traditional powerhouse pharmaceutical business, Cullity said. He said Ebos’s pharmacy business in NZ and Australia was solid and stable but had relatively low growth. “Double-digit growth rates are going to be very hard, so we need to broaden the group's base of earnings outside of Australia and New Zealand...

More Markets

The ‘crack cocaine’ of the stock market
Markets

The ‘crack cocaine’ of the stock market

Gamblers Anonymous meetings are filling up with people hooked on trading and betting.

The wildest, weirdest stock-market prices we’ve ever seen
Markets

The wildest, weirdest stock-market prices we’ve ever seen

Here’s a tour through history’s most entertaining price anomalies.

Light pre-Christmas trading for NZ sharemarket
Markets Market close

Light pre-Christmas trading for NZ sharemarket

The S&P/NZX 50 Index got into the festive spirit and closed at 13,074.74.

Graham Skellern 24 Dec 2024